Frank Eeckman, MD, Ph.D.

Managing Director – Healthcare

As Managing Director, Frank Eeckman advises healthcare companies on M&A, licensing and business strategies. In addition to his work for Woodside Capital Partners, Frank Eeckman, MD, PhD, is an analyst and consultant with NeuroInsights, a market research firm specializing in Neurotechnology. During the past 12 years, Frank was highly regarded for his due diligence work for biotechnology, pharmaceutical, medical device and diagnostic companies across a wide range of technology platform and indications on behalf of top tier Venture and Private Equity firms. He reviewed dozens of deals from seed to mezzanine stage, bringing his unique perspective regarding innovation, scientific rigor, clinical utility and commercial potential.

Frank is an expert in pattern recognition and artificial neural systems. He developed artificial vision and face recognition systems at Lawrence Livermore National Laboratory. Frank applied his pattern recognition skills to become an early innovator in the genomics revolution, leading the bioinformatics team for the Human Genome Project at Lawrence Berkeley National Lab. He helped launch three biotech startups and headed a discovery group at Parke-Davis (now Pfizer). He was a co-founder and CSO of Centient Consulting, a management consulting firm working with startups and investors. In that capacity he served as President and acting CEO for two biotech businesses. He has worked in the clinical trial process, at all levels, from Phase I to Phase IV after-market studies.

Frank holds an M.D. from the University of Ghent Medical School in Belgium and a PhD in Neuroscience from the University of California at Berkeley, where he was a Fulbright Scholar. He was a lecturer in the Medical School and a tutor at the UC Berkeley-UCSF Joint Medical Program. Frank is an avid triathlete who has competed in 11 ironman races. He qualified for, and ran the Boston marathon three times, and holds a coaching license from USA Cycling. He is on the board of the Brain Aneurysm Foundation and coaches for the Juvenile Diabetes Research Foundation (JDRF).